BACKGROUND AND PURPOSE: The prognostic value of dynamic contrast-enhanced MR
imaging in patients with glioblastoma is controversial. We investigated the added prognostic …

BACKGROUND AND PURPOSE: A number of parameters derived from dynamic contrast-
enhanced MR imaging and separate histologic features have been identified as potential …

Rationale and Objectives This study aimed to investigate whether volume transfer constant
(K trans) and volume of extravascular extracellular space per unit volume of tissue (V e) …

Purpose To determine whether semiquantitative histogram analysis of the normalized
cerebral blood volume (CBV) for an entire contrast material–enhanced lesion could be used …

BACKGROUND AND PURPOSE: The prognostic value of dynamic contrast-enhanced MR
imaging–derived plasma volume obtained in tumor and the contrast transfer coefficient has …

Purpose The identification of prognostic biomarkers plays a pivotal role in the management
of glioblastoma. The aim of this study was to assess the role of magnetic resonance dynamic …

BACKGROUND AND PURPOSE: The usefulness of pharmacokinetic parameters for glioma
grading has been reported based on the perfusion data from parts of entire-tumor volumes …

BACKGROUND AND PURPOSE: Tumor CBV is a prognostic and predictive marker for
patients with gliomas. Tumor CBV can be measured noninvasively with different MR imaging …

BACKGROUND AND PURPOSE: Prediction of survival in patients with glioblastomas is
important for individualized treatment planning. This study aimed to assess the prognostic …

Objectives To assess the usefulness of intra-tumor and peri-tumoral relative cerebral blood
volume (rCBV) in preoperative glioma grading. Patients and methods 21 patients with …